Glycopyrrolate
- Product NDC
- 25021-789
- 11-digit product format
- 250210789
- Labeler code
- 25021
- Product ID
- 25021-789_782eeda2-3645-44e6-874b-66372687bc12
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glycopyrrolate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA212871
- Marketing category
- ANDA
- Marketing start
- 2022-02-15
- Marketing end
- 0000-00-00
- Substance
- GLYCOPYRROLATE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-789-01 | 25021078901 | 10 VIAL in 1 CARTON (25021-789-01) > 1 mL in 1 VIAL | 10 vial | 2021-02-15 | 0000-00-00 | No | No | Current |
| 25021-789-02 | 25021078902 | 10 VIAL in 1 CARTON (25021-789-02) > 2 mL in 1 VIAL | 10 vial | 2021-02-15 | 0000-00-00 | No | No | Current |
| 25021-789-05 | 25021078905 | 10 VIAL in 1 CARTON (25021-789-05) > 5 mL in 1 VIAL | 10 vial | 2021-02-15 | 0000-00-00 | No | No | Current |